144510-38-3

Usage

Structure

The compound has a cyclohexane ring with two carbonyl groups at positions 1 and 3, and a benzoyl group at position 2, which has a difluoromethoxy group at position 4 and a fluorine atom at position 2.

Appearance

It is likely a solid at room temperature, given its molecular weight and structure, although the specific appearance is not provided in the material.

Solubility

Not specified in the material, but as a general rule, compounds with a significant amount of fluorine and oxygen (like this one) are often soluble in organic solvents.

Stability

Not specified in the material, but most pharmaceutical compounds are designed to be stable under normal conditions.

Safety

As with all pharmaceuticals, safety can vary based on dosage, individual health conditions, and potential interactions with other substances. The material mentions that it has shown tolerability in clinical trials, suggesting it is generally safe when used as directed.

Legal Status

Not specified in the material, but as a prescription medication, it would likely be subject to regulation in many jurisdictions.

Side Effects

Not specified in the material, but all medications have the potential for side effects, which would be detailed in the product information provided to healthcare providers and patients.

Drug Interactions

Not specified in the material, but all medications have the potential for interactions with other drugs, which would be detailed in the product information.

Manufacturer

Not specified in the material, but it would likely be produced by pharmaceutical companies with the appropriate licensing and regulatory approval.

Cost

Not specified in the material, but the cost would likely vary based on factors such as the country of purchase, the specific form of the drug, and whether it is purchased with or without insurance coverage.